Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS — Stella

Recruiting

Back to Acute Coronary Syndrome trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(9 sites)

France

Hospital of Béziers, Béziers

University Hospital of Bordeaux, Bordeaux

University Hospital of Montpellier, Montpellier

University Hospital of Nîmes, Nîmes

AP-HP Lariboisière Hospital, Paris

Key details

Sponsor

University Hospital, Montpellier

Enrollment target

~850 participants

Started

November 2023

Primary completion

May 2028

Age range

18 Years – 85 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov